Disease Info Card

Juvenile Spinal Muscular Atrophy

Information about Juvenile Spinal Muscular Atrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Juvenile Spinal Muscular Atrophy

Most recent studies have shown that Juvenile Spinal Muscular Atrophy shares some biological mechanisms with atrophy, compression-of-spinal-cord, dystrophy, flexed-fetal-attitude, hmn-(hereditary-motor-neuropathy)-proximal-type-i, hypertrophy, monomelic-amyotrophy, motor-neuron-disease, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathy, neuromuscular-diseases, primary-lateral-sclerosis, progressive-muscular-atrophy, sclerosis, spinal-cord-diseases, spinal-muscular-atrophies-of-childhood, spinal-muscular-atrophy, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Juvenile Spinal Muscular Atrophy, and have been seen in publications frequently: Aging, Cell Adhesion, Collateral Sprouting, Excretion, Innervation, Localization, Muscle Atrophy, Muscle Hypertrophy, Pathogenesis, Phagocytosis, Regeneration, Secretory Pathway, Sensitization, Swimming, Translation

Quite a number of genes have been found to play important roles in Juvenile Spinal Muscular Atrophy, such as C5, C7, CHKA, CHKB, CXCL10, DMD, IGFALS, IL13, NAIP, NLRP5, SMN1, SNRPN, SOD1, STMN1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.